Clinical Trial Update: Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies [Phase 1]

View source ↗

Summary

A Phase 1 safety study of Clostridium novyi-NT spores for solid tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Clostridium novyi-NT spores (Clostridium novyi-NT spores)

Snippet

Sponsor: BioMed Valley Discoveries, Inc | Conditions: Solid Tumor Malignancies | Phase 1 | Status: TERMINATED